Report shows slow progress on reducing antipsychotics, but AHCA renews 15% goal for 2013
By
McKnight's Staff
May 07, 2013
Skilled nursing providers fell well short of reaching a 15% reduction in off-label antipsychotic use by the end of 2012, the American Health Care Association announced Monday.
Pandemic bump in antipsychotics use raises questions about long-term care outcomes
By
Danielle Brown
Apr 12, 2022
The findings raise questions about the short- and long-term effects on the quality of care and health outcomes for residents, the authors say.
CMS, OIG agree on increasing scrutiny of psychotropic drug use
By
Joe Bush
Nov 18, 2022
The Centers for Medicare & Medicaid Services will be increasing its oversight of the use of psychotropic drugs to pay closer attention to certain classes, warned the lead author of a federal report identifying...
Stable LTC antipsychotic prescribing in 2020 may reflect success of U.S. reduction initiatives
By
Amy Novotney
Apr 16, 2021
University of Michigan researchers have found relatively minimal changes in central nervous system-active medication use among Michigan nursing home residents with dementia following the start of the COVID-19...
AHCA convention attendees urged to rise up in face of looming funding cuts; better moderate use of antipsychotics
By
McKnight's Staff
Oct 09, 2012
Long-term care providers were given the truth during the opening session of the 63rd annual convention of the American Health Care Association: More funding cuts are on the way. Among the other hot topics...
U.S. hospices lack standard for benzodiazepines, antipsychotics use: study
By
Alicia Lasek
Mar 28, 2023
Investigators have found significant variation in what is considered clinically appropriate use of these drugs for the U.S. hospice population.
Use of common hospice drugs varies widely by state, highlighting limited guidance
By
Alicia Lasek
Aug 16, 2022
Antipsychotics prescribing rates, for example, ranged from 62% for hospice beneficiaries in Oregon to 15% in Oklahoma, investigators say. Five states topped the prescriptions list.
FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
Nursing homes, feds hide sky-high antipsychotic use with dubious diagnoses: report
By
Alicia Lasek
Sep 20, 2021
At least one-fifth of nursing home residents are taking the drugs, many for schizophrenia, a diagnosis that has skyrocketed in these settings since 2012, a new investigation finds.
CMS leader mum on staffing mandate, delivers ‘back to basics’ message
By
James M. Berklan
Nov 08, 2023
A CMS leader steered clear of staffing mandate talk but highlighted a nursing home workforce campaign, renewed survey priorities, discharge processes and much more Tuesday.